02279 YONGHE MEDICAL
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.15X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 65.3% | Net Margin | N/A |
| Total Debt/Equity | 93.4% | Return on Equity | N/A |
| Price/Book | 1.88X | Return on Assets | N/A |
| (HKD 2.720) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | -240.72 | -592.83 | -94.15 | 143.80 | 174.42 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +59.4 | -529.6 | -165.5 | -17.6 | +338.0 |
| Earnings Per Share (HKD) | -0.481 | -1.194 | -0.184 | 0.359 | 0.464 |
| Earnings Per Share Growth (%) | +59.8 | -550.4 | -151.2 | -22.7 | +365.9 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | 0.093 | No dividend |
| P/E* (X) | N/A | N/A | N/A | 7.58 | 5.86 |
| Yield (%) | N/A | N/A | N/A | 3.42 | N/A |
| Dividend Share (%) | N/A | N/A | N/A | 25.92 | N/A |
| Book NAV (HKD) | 1.446 | 1.971 | 3.372 | 3.995 | N/A |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,804 | 1,777 | +1.5 | 1,413 |
| Operating Result | -203.512 | -532.87 | -61.8 | -107.43 |
| Profit Before Taxation | -255.291 | -585.219 | -56.4 | -109.466 |
| Taxation | -28.722 | -38.535 | -25.5 | -23.608 |
| Profit /( Loss) After Taxation | -226.569 | -546.684 | -58.6 | -85.858 |
| Minority Interests | -0.226 | -0.29 | -22.1 | 0 |
| Net Profit | -226.343 | -537.864 | -57.9 | -83.976 |
| Earnings Per Share () | -0.4807 | -1.1942 | -59.7 | -0.1836 |
| Dividend Per Share () | 0.0000 | 0.0000 | N/A | 0.0000 |
| Announcement Date | 2025-03-27 | 2024-03-28 | NA | 2023-03-30 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
